News | December 12, 2008

Siemens Receives FDA 510(k) Clearance for IQ-SPECT Technology

December 12, 2008 – Siemens Healthcare announced that it has received FDA 510(k) clearance for IQ-SPECT technology.

Originally introduced at the 2008 Society of Nuclear Medicine Annual Meeting, June 14-18, in New Orleans, IQ-SPECT is Siemens newest Symbia feature that enables a comprehensive cardiac evaluation, including perfusion, attenuation correction and calcium scoring in just five minutes.

IQ-SPECT technology is achieved with SMARTZOOM collimators that magnify the heart while imaging the rest of the torso under traditional conditions. Combining this cardio-centric orbit acquisition technique with fast, 3D iterative reconstruction enables more confident diagnoses and improved patient comfort, enhancing image quality, speed, productivity and throughput.

IQ-SPECT is 510k-cleared and commercially available on all Symbia S and T systems, and is field upgradeable for any existing systems.

For more information: www.siemens.com/healthcare

Related Content

advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Sponsored Content | Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
xSPECT Quant technology, SPECT/CT, Symbia Intevo, Siemens Healthineers, RSNA 2016
News | SPECT Imaging | December 06, 2016
December 6, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
Siemens Healthineers, Symbia Intevo SPECT/CT system, xSPECT Quant, RSNA 2016
Technology | SPECT-CT | October 18, 2016
October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healt
PET/CT

There is a growing focus on early diagnosis and prevention. Here, PET/CT imaging is used to look inside the stress center of the brain.

Feature | Imaging | September 07, 2016 | By Kirill Shalyaev, Ph.D.
Advanced imaging and hybrid modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), positron...
Valiance X12, SPECT/CT, CZT detectors, clinical trial

Tc99m MDP SPECT bone study images of a 35 year old male with right ankle pain. Top: Valiance X12. Bottom: Analog SPECT. Image courtesy of Molecular Dynamics.

News | SPECT-CT | August 24, 2016
Molecular Dynamics has successfully completed the first phase of a clinical trial to evaluate the Valiance X12 whole-...
GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install
News | SPECT-CT | May 05, 2016
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose...
UltraSPECT, dose management, lower dose SPECT

UltraSPECT's image reconstruction software can be used on older SPECT systems to allow lower-dose imaging. This is an example of the software's imaging capability using between 30-50 percent less dose.

Feature | April 20, 2015 | Dave Fornell
Nuclear myocardial perfusion imaging (MPI) with positron emission tomography (PET) and single-photon emission computed...
radiotherapeutics, nuclear medicine, PET, SPECT, MEDraysintell
News | March 10, 2015
The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell...
Overlay Init